Discovery of 5,7-Dimethoxy-2-(3,4,5-trimethoxyphenoxy)-chromen-4-one with Lipid Lowering Effects in Hepatocytes

The population with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is increasing. However, no medicine is indicated for treating these diseases clinically nowadays. Therefore, there is an urgent need to develop a new drug to overcome NAFLD and NASH. Capillarisin, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yi-Han, Yen, Chia-Hung, Lai, Chih-Chung, Lai, Hsuan-Yu, Hung, Hsin-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032471/
https://www.ncbi.nlm.nih.gov/pubmed/35455445
http://dx.doi.org/10.3390/ph15040449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032471/
https://www.ncbi.nlm.nih.gov/pubmed/35455445
http://dx.doi.org/10.3390/ph15040449

Ejemplares similares